Rebecca S Cook Selected Research

VU661013

9/2019

Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca S Cook Research Topics

Disease

52	Neoplasms (Cancer) 11/2021 - 12/2009
34	Breast Neoplasms (Breast Cancer) 11/2021 - 12/2009
10	Triple Negative Breast Neoplasms 01/2021 - 01/2012
9	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2013
2	Residual Neoplasm 01/2019 - 07/2012
2	Melanoma (Melanoma, Malignant) 01/2018 - 08/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Necrosis 01/2019
1	Virus Diseases (Viral Diseases) 06/2018
1	Cystitis 01/2018
1	Circulating Neoplastic Cells 01/2018
1	Urolithiasis 01/2018
1	Disease Progression 01/2018
1	Infections 01/2018
1	Carcinogenesis 02/2015
1	Inflammation (Inflammations) 01/2015
1	Lung Neoplasms (Lung Cancer) 05/2014
1	Pathologic Complete Response 02/2014

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 12/2020 - 03/2013
9	Proteins (Proteins, Gene)FDA Link 09/2019 - 02/2011
8	CytokinesIBA 01/2020 - 08/2013
8	Lapatinib (GW572016)FDA Link 01/2019 - 03/2011
6	Phosphotransferases (Kinase)IBA 01/2018 - 06/2011
6	Trastuzumab (Herceptin)FDA Link 02/2015 - 12/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 10/2013
5	Estrogen ReceptorsIBA 09/2019 - 01/2012
5	Phenobarbital (Luminal)FDA Link 01/2018 - 08/2013
4	Mechanistic Target of Rapamycin Complex 2IBA 01/2019 - 01/2016
4	c-Mer Tyrosine KinaseIBA 01/2019 - 12/2010
3	EnzymesIBA 11/2021 - 01/2018
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2016
3	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2011
3	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2013
3	human ERBB2 proteinIBA 06/2017 - 01/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 05/2014
2	ChemokinesIBA 01/2020 - 11/2018
2	navitoclaxIBA 09/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 02/2019 - 03/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 03/2013
2	Biological ProductsIBA 01/2019 - 10/2013
2	Fulvestrant (Faslodex)FDA Link 01/2018 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2012
2	LigandsIBA 01/2018 - 10/2013
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 07/2015 - 06/2011
2	Interleukin-10 (Interleukin 10)IBA 11/2014 - 08/2013
2	ClaudinsIBA 10/2013 - 08/2013
2	Tyrosine Kinase InhibitorsIBA 05/2012 - 06/2011
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	GlutaminaseIBA 01/2021
1	Delta CateninIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	cadherin 5IBA 12/2020
1	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2020
1	LuciferasesIBA 10/2019
1	Nucleic AcidsIBA 10/2019
1	VU661013IBA 09/2019
1	Everolimus FDA Link 09/2019
1	Proteasome InhibitorsIBA 01/2019
1	XL147IBA 01/2019
1	AntigensIBA 01/2019
1	Coenzymes (Enzyme Cofactors)IBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Therapeutic UsesIBA 11/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2018
1	NucleotidesIBA 11/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Aromatase InhibitorsIBA 01/2018
1	StruviteIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	A-factor (Streptomyces)IBA 06/2017
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 06/2017
1	CaspasesIBA 01/2017
1	Janus Kinase 2IBA 04/2016
1	Antisense OligonucleotidesIBA 12/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2015
1	Epidermal Growth Factor (EGF)IBA 12/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2015
1	locked nucleic acidIBA 12/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	CollagenIBA 02/2015
1	Interleukin-13IBA 11/2014
1	Interleukin-4 (Interleukin 4)IBA 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	Monoclonal AntibodiesIBA 07/2014
1	Hemoglobins (Hemoglobin)IBA 07/2014
1	Immunoglobulin G (IgG)IBA 07/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	ALW-II-41-27IBA 05/2014
1	Chemokine ReceptorsIBA 03/2014

Therapy/Procedure

10	Therapeutics 01/2019 - 01/2012
7	Drug Therapy (Chemotherapy) 01/2018 - 07/2012
5	Immunotherapy 01/2019 - 03/2016
4	Neoadjuvant Therapy 01/2018 - 07/2012
1	Radiotherapy 02/2015
1	Mastectomy (Mammectomy) 02/2014